Istituto per la Ricerca e l'Innovazione Biomedica

irib.cnr.it

Total trials

43

Active

15

Phase 3

0

Total enrollment

14,399

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Autism Spectrum Disorder21
  • Autism17
  • Asthma4
  • Allergic Rhinitis3
  • Healthy2
  • Parents1
  • Relationship, Professional Patient1
  • Eating Disorders1

Frequently asked questions about Istituto per la Ricerca e l'Innovazione Biomedica

How many clinical trials does Istituto per la Ricerca e l'Innovazione Biomedica have on ClinicalTrials.gov?
Istituto per la Ricerca e l'Innovazione Biomedica is listed as the lead sponsor on 43 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
How many of Istituto per la Ricerca e l'Innovazione Biomedica's trials are in Phase 3?
0 of Istituto per la Ricerca e l'Innovazione Biomedica's trials are in Phase 3.
What therapeutic areas does Istituto per la Ricerca e l'Innovazione Biomedica focus on?
Istituto per la Ricerca e l'Innovazione Biomedica's most-studied conditions on ClinicalTrials.gov are Autism Spectrum Disorder, Autism, Asthma, Allergic Rhinitis, Healthy.